- This event has passed.
Breakthrough Trends & Innovations in Biosimilars That Will Matter in 2021
June 9, 2021 @ 6:30 pm - 7:30 pm
Biologics are becoming increasingly important in terms of new drug products and sales. In this presentation we will discuss innovative approaches to expediting biosimilar development. The presentation will have a comprehensive overview,
1. Growth opportunities for Biosimilars – new trends and advancements
2. Key trends impacting commercialization.
3. Application (Oncology, Rheumatology, Inflammatory and Other Application)
4. Key manufacturers
Pfizer (US), Sandoz (Germany), Biocon (India), Fresenius Kabi AG (Germany), Boehringer Ingelheim (Germany), Amgen (US), Celltrion (South Korea), Probiomed (Mexico), Apotex (Canada), Gedeon Richter (Hungary), Mylan (US), Eli Lilly (US), Samsung Biologics (South Korea), Amega Biotech (Argentina), mAbxience (Switzerland), Biocad (Russia), Coherus Bioscience (US), and Stada Arzneimittel AG (Germany), Teva Pharmaceutical (Israel), Dr. Reddy’s Laboratories (India).
5. Key regions (United States, Canada and EU).
Join us for this interesting session.
